Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Juno gives up on lead CAR-T drug after deaths

Juno gives up on lead CAR-T drug after deaths

The company added that after discussions with its partner Celgene it had "decided not to move forward with the ROCKET trial or JCAR015 at this time, even though it generated important

Celgene bags US priority review for cancer metabolism drug

Celgene bags US priority review for cancer metabolism drug Celgene bags US priority review for cancer metabolism drug. First approval for enasidenib could be just six months away. ... IDH2 mutations occur in around 8-19% of AML patients, according to Celgene.

Celgene’s president and COO to retire

Celgene’s president and COO to retire Celgene’ s president and COO to retire. Scott Smith set to succeed Dr Jacqualyn Fouse from 1 April. ... On behalf of all Celgene employees, I wish Jackie the best in her retirement.”.

J&J gets CHMP backing for broader Darzalex use

J&J gets CHMP backing for broader Darzalex use Celgene's Revlimid (lenalidomide) plus dexamethasone and Takeda's Velcade (bortezomib) plus dexamethasone - have already been tried.

2016: The year when deal-makers took stock?

2016: The year when deal-makers took stock? As expected, the larger big pharma companies tend to be in the top rank in the number of in-licensing deals but smaller companies like Boehringer Ingelheim and Celgene punched well ... Meanwhile Celgene, with sales around 20% of those of Pfizer, did

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
S&H Medical Communications

S&H Medical Communications has a reputation for excellence, insight and energy. The collaborative team, from diverse backgrounds and supported by...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics